• FAQs

Uganda Virus Research Institute


News Updates

Bio-Safety and Bio-Security Leadership Skills Training

Uganda Virus Research Institute(UVRI) with support from the Government of Uganda received funding to conduct COVID-19 Trials under the NAV-COVID-19 study. The vioson of Uganda is that by 2030, Uganda will join other countries in Africa to lead vaccine trials research that has a major contribution to end the covid-19 pandemic and make significant contributions to world health.

Uganda Successfully Joins Trials Race For Coronavirus Drug

Uganda has launched clinical trials of a locally produced herbal treatment for COVID-19. The therapeutic drug was developed by a think-tank of local scientists - under the Presidential Initiative on Epidemics. The product: UBV-01N is the first Ugandan natural chemotherapeutic medicine to go through an international level of the clinical trial process. Michael Baleke reports from Kampala.